Allicurso 200 mg Ursodeoxycholic Acid Tablet

Adult dose

1. For cholesterol gallstones: 200-250 mg orally three times a day. 2. For primary biliary cholangitis: 200-300 mg orally three times a day with meals. 3. For chronic hepatitis C: 200 mg orally three times a day. If necessary, the dosage can be increased to 300 mg orally three times a day.

This medication should not be taken by individuals allergic to specific ingredients. Patients with severe bile duct obstruction may experience worsened symptoms due to this medication and should not take it. Caution is also needed for patients with fulminant hepatitis as this medication can aggravate symptoms. Patients with radio-lucent calcified gallstones or those without gallbladder function should not take this medication. Pregnant women, nursing mothers, and children should also avoid this medication. Patients with kidney disease and acute peptic ulcer may worsen their symptoms if they take this medication. It is advisable for patients with enteritis, such as Crohn's disease, to avoid taking this medication. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. While taking this medication, it is important not to use oral diabetes medications, specific antacids, lipid-lowering drugs, or any medications that may harm the liver as these can interfere with the effectiveness of this medication or increase the risk of side effects. Patients with severe pancreatic disease, stones in the bile duct, variceal bleeding, hepatic encephalopathy, ascites, and acute liver disease should consult a specialist before taking this medication. If gastrointestinal symptoms like diarrhea, nausea, vomiting, loss of appetite, or abdominal pain occur during use, or if allergic symptoms like itching or rash develop, stop taking the medication immediately and contact a healthcare professional. Additionally, if fever, cough, or difficulty breathing occurs, the possibility of interstitial pneumonia arises, so immediate medical attention is required. Also, if general fatigue, dizziness, liver function abnormalities, or leukopenia occur, stop taking the medication and consult a professional. Patients with liver cirrhosis or the elderly should use this medication with caution and regularly undergo liver function tests for safety. Gallstone dissolution therapy can take a prolonged period (more than 6 months), so regular monitoring of treatment progress is advised, and treatment may be discontinued if ineffective. This medication should be stored out of the reach of children in a safe place and kept sealed in its original container to maintain the quality and safety of the medication.

Serious side effects

Symptoms related to liver abnormalities (jaundice), such as fever, cough, difficulty breathing, and an increase in serum bilirubin levels.

Mild side effects

• Occasionally diarrhea
• loose stools
• nausea
• vomiting
• loss of appetite
• epigastric pain
• and rarely abdominal pain
• constipation
• heartburn
• discomfort in the stomach

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius. This will help preserve the medication's effectiveness and safety.

Appearance

Domestic use: white round tablets For export: white round film-coated tablets

Package unit

Domestic use: 30 tablets/PTP (10 tablets/PTP × 3), 30 tablets/bottle, 300 tablets/bottle For export: 20 tablets (10 tablets/PTP × 2), 30 tablets (10 tablets/PTP × 3), 100 tablets (10 tablets/PTP × 10)